Latest Investment News

Janus Electric has inked a $5 million share placement and exclusive distribution deal with EVUNI, setting the stage for its heavy transport electrification technology to enter the sub-Saharan region.

Mt Malcolm Mines has launched a comprehensive JORC-compliant Mineral Resource Estimation for its Malcolm Gold Project in Western Australia, leveraging strong recent drilling and bulk sampling results. The initiative aims to underpin future resource growth and development in a prolific gold district.

Eastern Resources Limited has secured a farm-in agreement to earn up to 80% interest in Queensland’s Marengo Gold Project, a historically rich goldfield with promising high-grade assays and multiple exploration targets.

Nyrada Inc. has announced successful Phase I trial results for its lead drug candidate Xolatryp, confirming safety and pharmacokinetics that pave the way for a Phase IIa trial targeting heart attack patients next year.

Elixir Energy has commenced drilling the Diona-1 conventional gas-oil exploration well in Queensland’s Surat-Bowen Basin, aiming to unlock new production potential and secure long-term asset retention.

Black Rock Mining has secured A$10 million through an equity placement to initiate early construction activities at its Mahenge Graphite Project in Tanzania, marking a pivotal step towards full project development.

Dynamic Metals Limited has identified a significant gold-in-soil anomaly at its Courvoisier prospect within the Widgiemooltha Project, signalling promising potential for bedrock-hosted gold mineralisation. Meanwhile, assay results from recent drilling at Chalice South are eagerly awaited.

Mustang Energy has initiated a significant 2,000-metre diamond drilling campaign at the Surprise Creek Uranium-Copper Project in Canada’s Athabasca Basin, aiming to extend previously identified high-grade uranium mineralisation.

EMVision Medical Devices launches a $2 million Share Purchase Plan offering shares at a 16.4% discount, bundled with free options exercisable at $3.40, aiming to bolster clinical and commercial milestones.

Synlait Milk Limited reports a modest profit turnaround in FY25 and announces a major sale of its North Island assets to Abbott, aiming to reduce debt and sharpen its focus on core operations.

Synlait has agreed to sell its North Island assets to global healthcare giant Abbott for approximately US$178 million, marking a strategic reset focused on debt reduction and operational simplification. The deal, expected to close by April 2026, positions Synlait to concentrate on its South Island operations and explore new growth avenues.

Gold Road Resources Limited shares have been suspended from the ASX following court approval of its acquisition by Gruyere Holdings Pty Ltd, marking a pivotal step in the gold miner’s corporate journey.